Table 1.
Number of participants, sex and age distributions in the groups.
| Group I HCPs |
Group II COVID-19 ICU |
Group III COVID-19 Non-ICU |
Group IV APS |
p | |
|---|---|---|---|---|---|
| No. of Participants |
58 | 45 | 89 | 52 | |
| Age (years) | |||||
| Median (IQR), (min–max) |
46 (35–55) (24–64) |
70 (58–78) (42–85) |
62 (52–67) (27–78) |
39 (34–56) (23–80) |
p < 0.0001 * HCPs-COVID-19 group II: p < 0.0001, HCPs-COVID-19 group III: p < 0.0001, HCPs-APS: ns, COVID-19 group II-APS: p < 0.0001. COVID-19 group III-APS: p < 0.0001. COVID-19 group II–COVID-19 group III: p = 0.02. |
| Sex (n) | |||||
| Female | 45 | 8 | 31 | 36 |
p < 0.0001 ** HCPs-COVID-19 group II: p < 0.0001, HCPs-COVID-19 group III: p < 0.0001, HCPs-APS: ns, COVID-19 group II-APS: p < 0.0001. COVID-19 group III-APS: p < 0.0001. COVID-19 group II-COVID-19 group III: p = 0.04. |
| Male | 13 | 37 | 58 | 16 |
* Kruskal–Wallis test with Dunn’s multiple comparison test was used for age; ** χ2 test was used for sex.